US Stock MarketDetailed Quotes
BNTX BioNTech
- 120.720
- +2.180+1.84%
Close Nov 27 16:00 ET
- 120.720
- 0.0000.00%
Post 20:01 ET
28.94BMarket Cap-58945P/E (TTM)
121.510High118.600Low604.80KVolume119.000Open118.540Pre Close72.74MTurnover0.65%Turnover Ratio29.87P/E (Static)239.74MShares131.49052wk High1.43P/B11.24BFloat Cap76.53052wk Low--Dividend TTM93.12MShs Float457.931Historical High--Div YieldTTM2.46%Amplitude12.361Historical Low120.274Avg Price1Lot Size
BioNTech Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 39.04%1.24B | -23.26%128.7M | -85.31%187.6M | -77.94%3.82B | -65.43%1.48B | -74.13%895.3M | -94.75%167.7M | -79.97%1.28B | -8.78%17.31B | -22.67%4.28B |
| Operating revenue | 39.04%1.24B | -23.26%128.7M | -85.31%187.6M | -77.94%3.82B | -65.43%1.48B | -74.13%895.3M | -94.75%167.7M | -79.97%1.28B | -8.78%17.31B | -22.67%4.28B |
| Cost of revenue | 10.57%178.9M | -63.29%59.8M | -38.44%59.1M | -79.97%599.8M | -2.40%179.1M | -78.51%161.8M | -78.69%162.9M | -92.58%96M | 2.87%3B | -68.54%183.5M |
| Gross profit | 45.32%1.07B | 1,335.42%68.9M | -89.12%128.5M | -77.51%3.22B | -68.25%1.3B | -72.92%733.5M | -99.80%4.8M | -76.75%1.18B | -10.89%14.32B | -17.27%4.09B |
| Operating expense | 59.81%1.06B | 82.20%1.04B | 20.72%635.7M | 15.07%2.32B | -11.46%559.9M | 35.52%660.4M | 11.48%568.1M | 60.65%526.6M | 76.77%2.01B | 72.88%632.4M |
| Selling and administrative expenses | -1.95%150.5M | 33.28%183.8M | 6.94%132.6M | 3.05%557.7M | -1.86%142.3M | 2.88%153.5M | -4.57%137.9M | 17.98%124M | 65.40%541.2M | 3.72%145M |
| -Selling and marketing expense | 25.69%18.1M | -28.73%12.9M | 27.87%15.6M | 5.38%62.7M | 23.29%18M | 12.50%14.4M | 1.69%18.1M | -14.69%12.2M | 18.06%59.5M | -18.44%14.6M |
| -General and administrative expense | -4.82%132.4M | 42.65%170.9M | 4.65%117M | 2.76%495M | -4.68%124.3M | 1.98%139.1M | -5.45%119.8M | 23.13%111.8M | 74.02%481.7M | 6.97%130.4M |
| Research and development costs | 10.52%550.3M | 56.56%584.6M | 51.95%507.5M | 16.01%1.78B | 13.34%577.8M | 45.67%497.9M | -6.56%373.4M | 16.86%334M | 61.93%1.54B | 87.77%509.8M |
| Other operating expenses | 3,840.00%354.6M | 369.54%266.7M | -106.41%-4.4M | 61.14%-25.8M | -1,246.22%-160.2M | 208.43%9M | 250.26%56.8M | 208.72%68.6M | 51.99%-66.4M | 73.85%-11.9M |
| Operating profit | -85.64%10.5M | -71.52%-966.2M | -177.51%-507.2M | -92.65%904.2M | -78.63%740M | -96.71%73.1M | -129.30%-563.3M | -86.23%654.4M | -17.57%12.3B | -24.46%3.46B |
| Net non-operating interest income expense | -3.95%148.2M | 6.15%160.4M | 229.08%175.4M | 1,081.42%349.7M | -124.52%-9M | 4,438.24%154.3M | 3,613.95%151.1M | -79.92%53.3M | 214.73%29.6M | 310.92%36.7M |
| Non-operating interest income | -0.06%156.2M | 10.04%167.7M | 118.83%180.1M | 637.32%357.6M | -114.43%-5.6M | 1,929.87%156.3M | 10,060.00%152.4M | -69.75%82.3M | 3,133.33%48.5M | 12,833.33%38.8M |
| Non-operating interest expense | 300.00%8M | 461.54%7.3M | -83.79%4.7M | ---- | ---- | -53.49%2M | -77.59%1.3M | 332.84%29M | ---- | ---- |
| Total other finance cost | ---- | ---- | ---- | -58.20%7.9M | ---- | ---- | ---- | ---- | -30.77%18.9M | ---- |
| Other net income (expense) | -110.92%-67.8M | 327.77%620.7M | -320.91%-326.5M | |||||||
| Gain on sale of security | ---- | ---- | ---- | -106.16%-38.4M | ---- | ---- | ---- | ---- | 304.74%623.7M | -306.31%-323.5M |
| Special income (charges) | ---- | ---- | ---- | -880.00%-29.4M | ---- | ---- | ---- | ---- | 66.67%-3M | ---- |
| -Less:Other special charges | ---- | ---- | ---- | 880.00%29.4M | ---- | ---- | ---- | ---- | -66.67%3M | ---- |
| Income before tax | -30.21%158.7M | -95.49%-805.8M | -146.88%-331.8M | -90.84%1.19B | -79.10%663.2M | -90.70%227.4M | -117.77%-412.2M | -85.90%707.7M | -13.91%12.95B | -32.70%3.17B |
| Income tax | -158.98%-39.4M | 100.90%2M | -108.13%-16.7M | -92.73%255.8M | -77.03%205.3M | -89.87%66.8M | -134.27%-221.8M | -84.42%205.5M | -25.96%3.52B | -42.24%893.9M |
| Net income | 23.35%198.1M | -324.26%-807.8M | -162.74%-315.1M | -90.14%930.3M | -79.91%457.9M | -91.00%160.6M | -111.39%-190.4M | -86.42%502.2M | -8.34%9.43B | -28.03%2.28B |
| Net income continuous Operations | 23.35%198.1M | -324.26%-807.8M | -162.74%-315.1M | -90.14%930.3M | -79.91%457.9M | -91.00%160.6M | -111.39%-190.4M | -86.42%502.2M | -8.34%9.43B | -28.03%2.28B |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 23.35%198.1M | -324.26%-807.8M | -162.74%-315.1M | -90.14%930.3M | -79.91%457.9M | -91.00%160.6M | -111.39%-190.4M | -86.42%502.2M | -8.34%9.43B | -28.03%2.28B |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 23.35%198.1M | -324.26%-807.8M | -162.74%-315.1M | -90.14%930.3M | -79.91%457.9M | -91.00%160.6M | -111.39%-190.4M | -86.42%502.2M | -8.34%9.43B | -28.03%2.28B |
| Basic earnings per share | 22.39%0.82 | -325.32%-3.36 | -163.29%-1.31 | -90.02%3.87 | -79.64%1.91 | -90.98%0.67 | -111.52%-0.79 | -86.32%2.07 | -8.06%38.78 | -27.62%9.38 |
| Diluted earnings per share | 22.73%0.81 | -325.32%-3.36 | -163.90%-1.31 | -89.86%3.83 | -79.59%1.89 | -90.54%0.66 | -112.25%-0.79 | -85.60%2.05 | -4.69%37.77 | -23.91%9.26 |
| Dividend per share | ||||||||||
| Currency Unit | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
